Sort   by:  
 Page size 
UnknownViral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
Not available
S-EPMC11793053 | biostudies-literature
UnknownPooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
Not available
S-EPMC10686688 | biostudies-literature
UnknownSafety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
Not available
S-EPMC10134004 | biostudies-literature
UnknownSafety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial.
Not available
S-EPMC10579289 | biostudies-literature
UnknownOne Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
Not available
S-EPMC10552586 | biostudies-literature
UnknownRecurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19.
Not available
S-EPMC9614575 | biostudies-literature
UnknownSymptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Not available
S-EPMC10052317 | biostudies-literature
UnknownSafety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC11566225 | biostudies-literature
UnknownEmergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.
Not available
S-EPMC9675946 | biostudies-literature
UnknownCancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis.
Not available
S-EPMC7002399 | biostudies-literature
Sort   by:  
 Page size